9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bisoprolol, Known to Be a Selective β 1-Receptor Antagonist, Differentially but Directly Suppresses I K(M) and I K(erg) in Pituitary Cells and Hippocampal Neurons

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bisoprolol (BIS) is a selective antagonist of β 1 adrenergic receptors. We examined the effects of BIS on M-type K + currents (I K(M)) or erg-mediated K + currents (I K(erg)) in pituitary GH 3, R1220 cells, and hippocampal mHippoE-14 cells. As GH 3 cells were exposed to BIS, amplitude of I K(M) was suppressed with an IC 50 value of 1.21 μM. The BIS-induced suppression of I K(M) amplitude was not affected by addition of isoproterenol or ractopamine, but attenuated by flupirtine or ivabradine. In cell-attached current, BIS decreased the open probability of M-type K + (K M) channels, along with decreased mean opening time of the channel. BIS decreased I K(erg) amplitude with an IC 50 value of 6.42 μM. Further addition of PD-118057 attenuated BIS-mediated inhibition of I K(erg). Under current-clamp conditions, BIS depolarization increased the firing of spontaneous action potentials in GH 3 cells; addition of flupirtine, but not ractopamine, reversed BIS-induced firing rate. In R1220 cells, BIS suppressed I K(M); subsequent application of ML-213(Kv7.2 channel activator) reversed BIS-induced suppression of the current. In hippocampal mHippoE-14 neurons, BIS inhibited I K(M) to a greater extent compared to its depressant effect on I K(erg). This demonstrated that in pituitary cells and hippocampal neurons the presence of BIS is capable of directly and differentially suppressing I K(M) and I K(erg), despite its antagonism of β 1-adrenergic receptors.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels.

          In this study, we examine whether an anti-inflammatory thiourea derivative, compound #326, actions on ion channels. The effects of compound #326 on Ca2+ -activated K+ channels were evaluated by patch-clamp recordings obtained in cell-attached, inside-out or whole-cell configuration. In pituitary GH3 cells, compound #326 increased the amplitude of Ca2+ -activated K+ currents (IK(Ca) ) with an EC50 value of 11.6 μM, which was reversed by verruculogen, but not tolbutamide or TRAM-34. Under inside-out configuration, a bath application of compound #326 raised the probability of large-conductance Ca2+ -activated K+ (BKCa ) channels. The activation curve of BKCa channels was shifted to less depolarised potential with no modification of the gating charge of the curve; consequently, the difference of free energy was reduced in the presence of this compound. Compound #326-stimulated activity of BKCa channels is explained by a shortening of mean closed time, despite its inability to alter single-channel conductance. Neither delayed-rectifier nor erg-mediated K+ currents was modified. Compound #326 decreased the peak amplitude of voltage-gated Na+ current with no clear change in the overall current-voltage relationship of this current. In HEK293T cells expressing α-hSlo, compound #326 enhanced BKCa channels effectively. Intriguingly, the inhibitory actions of compound #326 on interleukin 1β in lipopolysaccharide-activated microglia were significantly reversed by verruculogen, whereas BKCa channel inhibitors suppressed the expressions of inducible nitric oxide synthase. The BKCa channels could be an important target for compound #326 if similar in vivo results occur, and the multi-functionality of BKCa channels in modulating microglial immunity merit further investigation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            M‐type K + channels in peripheral nociceptive pathways

            Pathological pain is a hyperexcitability disorder. Since the excitability of a neuron is set and controlled by a complement of ion channels it expresses, in order to understand and treat pain, we need to develop a mechanistic insight into the key ion channels controlling excitability within the mammalian pain pathways and how these ion channels are regulated and modulated in various physiological and pathophysiological settings. In this review, we will discuss the emerging data on the expression in pain pathways, functional role and modulation of a family of voltage‐gated K+ channels called ‘M channels’ (KCNQ, Kv7). M channels are increasingly recognized as important players in controlling pain signalling, especially within the peripheral somatosensory system. We will also discuss the therapeutic potential of M channels as analgesic drug targets. Linked Articles This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc/
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity.

              A variety of drugs has been reported to cause acquired long QT syndrome through inhibition of the IKr channel. Screening compounds in early discovery and development stages against their ability to inhibit IKr or the hERG channel has therefore become an indispensable procedure in the pharmaceutical industry. In contrast to numerous hERG channel blockers discovered during screening, only (3R,4R)-4-[3-(6-methoxyquinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5-trifluoro-phenyl)-prop-2-ynyl]-piperidine-3-carboxylic acid (RPR260243) has been reported so far to enhance the hERG current. In this article, we describe several potent mechanistically distinct hERG channel enhancers. One example is PD-118057 (2-{4-[2-(3,4-dichloro-phenyl)-ethyl]-phenylamino}-benzoic acid) which produced average increases of 5.5 +/- 1.1, 44.8 +/- 3.1, and 111.1 +/- 21.7% in the peak tail hERG current at 1, 3, and 10 muM, respectively, in human embryonic kidney 293 cells. PD-118057 did not affect the voltage dependence and kinetics of gating parameters, nor did it require open conformation of the channel. In isolated guinea pig cardiomyocytes, PD-118057 showed no major effect on I(Na), I(Ca,L), I(K1), and I(Ks). PD-118057 shortened the action potential duration and QT interval in arterially perfused rabbit ventricular wedge preparation in a concentration-dependent manner. The presence of 3 muM PD-118057 prevented action potential duration and QT prolongation caused by dofetilide. "Early after-depolarizations" induced by dofetilide were also completely eliminated by 3 microM PD-118057. Although further investigation is warranted to evaluate the therapeutic value and safety profile of these compounds, our data support the notion that hERG activation by pharmaceuticals may offer a new approach in the treatment of delayed repolarization conditions, which may occur in patients with inherited or acquired long QT syndrome, congestive heart failure, and diabetes.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                02 February 2019
                February 2019
                : 20
                : 3
                : 657
                Affiliations
                [1 ]Department of Anesthesia, An Nan Hospital, China Medical University, Tainan 70965, Taiwan; edmundsotw@ 123456gmail.com (E.C.S.); D23923@ 123456mail.tmanh.org.tw (N.-P.F.)
                [2 ]Department of Anesthesia, China Medical University, Taichung 40402, Taiwan
                [3 ]Graduate Institute of Medical Sciences, Chang Jung Christian University, Tainan 71101, Taiwan; syko@ 123456mail.cjcu.edu.tw
                [4 ]Department of Emergency Medicine, An Nan Hospital, China Medical University, Tainan 70965, Taiwan
                [5 ]Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan 70101, Taiwan
                [6 ]Department of Physiology, National Cheng Kung University Medical College, Tainan 70101, Taiwan
                Author notes
                [* ]Correspondence: snwu@ 123456mail.ncku.edu.tw ; Tel.: +886-6-2353535-5334; Fax: +886-6-2362780
                Article
                ijms-20-00657
                10.3390/ijms20030657
                6386942
                30717422
                d1a25e95-aea9-434a-abce-b7902c1e3450
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 07 January 2019
                : 30 January 2019
                Categories
                Article

                Molecular biology
                bisoprolol,m-type k+ current,m-type k+ channel. erg-mediated k+ current,membrane potential,pituitary cell

                Comments

                Comment on this article